Market Overview:
The global medical tartaric acid market is expected to grow at a CAGR of 5.5% during the forecast period from 2018 to 2030. The growth in this market can be attributed to the increasing demand for chiral catalysts and complex natural product molecules in the pharmaceutical and biotechnology industries. Additionally, the growing demand for antioxidants and deoxidants in various end-use applications is also contributing to the growth of this market.
Product Definition:
Medical Tartaric Acid is a white crystalline powder that is used as a flavoring agent and adjuvant in pharmaceutical preparations.
Organic Synthesis:
Organic synthesis is the process through which a number of organic compounds are manufactured. Organic synthesis includes the generation of varied products such as tartaric acid, alkyl halides, alcohols and ketones. The most important raw materials used in organic syntheses include carbon (carbon monoxide and carbon dioxide), hydrogen, nitrogen and sulfur.
Artificially Synthesized:
Artificially synthesized tartaric acid is used as a food additive in the form of potassium salt. It has various applications such as it can be used in baked goods to enhance their quality and taste, or it can be used for manufacturing certain pharmaceutical drugs.
Application Insights:
Drug industrial raw materials was the dominant application segment and accounted for a revenue share of over 60% in 2017. The growing importance of medical tartaric acid as an intermediate chemical in the production of pharmaceutical drugs cannot be overemphasized. It is used to produce salts such as potassium bitartrate, sodium tartrate, calcium tartarate and others which are widely utilized in drug formulations.
The antioxidant segment is expected to witness significant growth during the forecast period owing to rising demand from various end-use industries including food & beverages, cosmetics, nutraceuticals among others. Antioxidants help retard or prevent oxidation damage caused by free radicals present in living organisms that occur naturally or are produced through normal metabolism processes within cells. As per WHO (2016), there is a high demand for antioxidants due to rising awareness about health hazards associated with free radicals along with increasing consumption of processed foods across the globe which has further driven market growth during past few years (Ref).
Regional Analysis:
North America was the largest regional market in 2017 owing to the presence of a large number of pharmaceutical industries. The region is expected to maintain its dominance over the forecast period due to increasing R&D activities and high healthcare spending. In addition, growing focus on drug discovery by major companies is also expected to drive this regional market during the forecast period.
Asia Pacific is anticipated to be one of the fastest-growing regions with a CAGR exceeding 6% from 2018 to 2030 owing for tartaric acid being used as an excipient in medicines for various diseases such as cancer, diabetes, HIV infection & AIDS, arthritis and others. Moreover, increasing production capacities coupled with rising demand from end-use industries will drive this regional market during the projected time frame.
Growth Factors:
- Increasing demand for tartaric acid in food and beverage industry as a flavoring agent and preservative.
- Rising demand from pharmaceuticals and nutraceuticals industries for the use of tartaric acid in various formulations.
- Growing application of tartaric acid in cosmetic products as an antioxidant and skin-conditioning agent.
- Increasing research on the therapeutic potential of tartaric acid for treating various diseases such as cancer, diabetes, etc.
Scope Of The Report
Report Attributes
Report Details
Report Title
Medical Tartaric Acid Market Research Report
By Type
Organic Synthesis, Artificially Synthesized
By Application
Drug Industrial Raw Materials, Chiral Catalyst, Synthesis of Complex Natural Product Molecules, Antioxidant, Deoxidant
By Companies
Giovanni Randi S.P.A. Randi Group, Boehringer-Ingelheim, Hangzhou Bao Jing Biochemical Co., LTD, Chang Mao Biochemistry Engineering Co., LTD, SYNFINE, CARBOMER, Wonda Science, CAMBREX, Labseeker Inc, GARAN S.K, AlliChem, LLC
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
244
Number of Tables & Figures
171
Customization Available
Yes, the report can be customized as per your need.
Global Medical Tartaric Acid Market Report Segments:
The global Medical Tartaric Acid market is segmented on the basis of:
Types
Organic Synthesis, Artificially Synthesized
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Drug Industrial Raw Materials, Chiral Catalyst, Synthesis of Complex Natural Product Molecules, Antioxidant, Deoxidant
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Giovanni Randi S.P.A. Randi Group
- Boehringer-Ingelheim
- Hangzhou Bao Jing Biochemical Co., LTD
- Chang Mao Biochemistry Engineering Co., LTD
- SYNFINE
- CARBOMER
- Wonda Science
- CAMBREX
- Labseeker Inc
- GARAN S.K
- AlliChem, LLC
Highlights of The Medical Tartaric Acid Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Organic Synthesis
- Artificially Synthesized
- By Application:
- Drug Industrial Raw Materials
- Chiral Catalyst
- Synthesis of Complex Natural Product Molecules
- Antioxidant
- Deoxidant
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Medical Tartaric Acid Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Medical tartaric acid is a medication used to treat gout. It is a type of acid that helps to reduce the amount of uric acid in the body.
Some of the major players in the medical tartaric acid market are Giovanni Randi S.P.A. Randi Group, Boehringer-Ingelheim, Hangzhou Bao Jing Biochemical Co., LTD, Chang Mao Biochemistry Engineering Co., LTD, SYNFINE, CARBOMER, Wonda Science, CAMBREX, Labseeker Inc, GARAN S.K, AlliChem, LLC.
The medical tartaric acid market is expected to grow at a compound annual growth rate of 5.5%.
1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Medical Tartaric Acid Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. Medical Tartaric Acid Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. Medical Tartaric Acid Market - Supply Chain
4.5. Global Medical Tartaric Acid Market Forecast
4.5.1. Medical Tartaric Acid Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. Medical Tartaric Acid Market Size (000 Units) and Y-o-Y Growth
4.5.3. Medical Tartaric Acid Market Absolute $ Opportunity
5. Global Medical Tartaric Acid Market Analysis and Forecast by Type
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Type
5.2.2. Y-o-Y Growth Projections by Type
5.3. Medical Tartaric Acid Market Size and Volume Forecast by Type
5.3.1. Organic Synthesis
5.3.2. Artificially Synthesized
5.4. Absolute $ Opportunity Assessment by Type
5.5. Market Attractiveness/Growth Potential Analysis by Type
6. Global Medical Tartaric Acid Market Analysis and Forecast by Application
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by Application
6.2.2. Y-o-Y Growth Projections by Application
6.3. Medical Tartaric Acid Market Size and Volume Forecast by Application
6.3.1. Drug Industrial Raw Materials
6.3.2. Chiral Catalyst
6.3.3. Synthesis of Complex Natural Product Molecules
6.3.4. Antioxidant
6.3.5. Deoxidant
6.4. Absolute $ Opportunity Assessment by Application
6.5. Market Attractiveness/Growth Potential Analysis by Application
7. Global Medical Tartaric Acid Market Analysis and Forecast by Sales Channel
7.1. Market Trends
7.2. Introduction
7.2.1. Basis Point Share (BPS) Analysis by Sales Channel
7.2.2. Y-o-Y Growth Projections by Sales Channel
7.3. Medical Tartaric Acid Market Size and Volume Forecast by Sales Channel
7.3.1. Manufacturer/Distributor/Service Provider
7.3.2. Aftermarket
7.4. Absolute $ Opportunity Assessment by Sales Channel
7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel
8. Global Medical Tartaric Acid Market Analysis and Forecast by Region
8.1. Market Trends
8.2. Introduction
8.2.1. Basis Point Share (BPS) Analysis by Region
8.2.2. Y-o-Y Growth Projections by Region
8.3. Medical Tartaric Acid Market Size and Volume Forecast by Region
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. Asia Pacific
8.3.5. Middle East and Africa (MEA)
8.4. Absolute $ Opportunity Assessment by Region
8.5. Market Attractiveness/Growth Potential Analysis by Region
8.6. Global Medical Tartaric Acid Demand Share Forecast, 2019-2026
9. North America Medical Tartaric Acid Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.2. North America Medical Tartaric Acid Market Size and Volume Forecast by Country
9.2.1. U.S.
9.2.2. Canada
9.3. Absolute $ Opportunity Assessment by Country
9.4. North America Medical Tartaric Acid Market Size and Volume Forecast by Application
9.4.1. Drug Industrial Raw Materials
9.4.2. Chiral Catalyst
9.4.3. Synthesis of Complex Natural Product Molecules
9.4.4. Antioxidant
9.4.5. Deoxidant
9.5. Basis Point Share (BPS) Analysis by Application
9.6. Y-o-Y Growth Projections by Application
9.7. North America Medical Tartaric Acid Market Size and Volume Forecast by Type
9.7.1. Organic Synthesis
9.7.2. Artificially Synthesized
9.8. Basis Point Share (BPS) Analysis by Type
9.9. Y-o-Y Growth Projections by Type
9.10. Market Attractiveness/Growth Potential Analysis
9.10.1. By Country
9.10.2. By Product Type
9.10.3. By Application
9.10.4. By Sales Channel
9.11. North America Medical Tartaric Acid Demand Share Forecast, 2019-2026
10. Latin America Medical Tartaric Acid Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Latin America Average Pricing Analysis
10.2. Latin America Medical Tartaric Acid Market Size and Volume Forecast by Country
10.2.1. Brazil
10.2.2. Mexico
10.2.3. Rest of Latin America
10.3. Absolute $ Opportunity Assessment by Country
10.4. Latin America Medical Tartaric Acid Market Size and Volume Forecast by Application
10.4.1. Drug Industrial Raw Materials
10.4.2. Chiral Catalyst
10.4.3. Synthesis of Complex Natural Product Molecules
10.4.4. Antioxidant
10.4.5. Deoxidant
10.5. Basis Point Share (BPS) Analysis by Application
10.6. Y-o-Y Growth Projections by Application
10.7. Latin America Medical Tartaric Acid Market Size and Volume Forecast by Type
10.7.1. Organic Synthesis
10.7.2. Artificially Synthesized
10.8. Basis Point Share (BPS) Analysis by Type
10.9. Y-o-Y Growth Projections by Type
10.10. Market Attractiveness/Growth Potential Analysis
10.10.1. By Country
10.10.2. By Product Type
10.10.3. By Application
10.10.4. By Sales Channel
10.11. Latin America Medical Tartaric Acid Demand Share Forecast, 2019-2026
11. Europe Medical Tartaric Acid Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Europe Average Pricing Analysis
11.2. Europe Medical Tartaric Acid Market Size and Volume Forecast by Country
11.2.1. Germany
11.2.2. France
11.2.3. Italy
11.2.4. U.K.
11.2.5. Spain
11.2.6. Russia
11.2.7. Rest of Europe
11.3. Absolute $ Opportunity Assessment by Country
11.4. Europe Medical Tartaric Acid Market Size and Volume Forecast by Application
11.4.1. Drug Industrial Raw Materials
11.4.2. Chiral Catalyst
11.4.3. Synthesis of Complex Natural Product Molecules
11.4.4. Antioxidant
11.4.5. Deoxidant
11.5. Basis Point Share (BPS) Analysis by Application
11.6. Y-o-Y Growth Projections by Application
11.7. Europe Medical Tartaric Acid Market Size and Volume Forecast by Type
11.7.1. Organic Synthesis
11.7.2. Artificially Synthesized
11.8. Basis Point Share (BPS) Analysis by Type
11.9. Y-o-Y Growth Projections by Type
11.10. Market Attractiveness/Growth Potential Analysis
11.10.1. By Country
11.10.2. By Product Type
11.10.3. By Application
11.10.4. By Sales Channel
11.11. Europe Medical Tartaric Acid Demand Share, 2019-2026
12. Asia Pacific Medical Tartaric Acid Market Analysis and Forecast
12.1. Introduction
12.1.1. Basis Point Share (BPS) Analysis by Country
12.1.2. Y-o-Y Growth Projections by Country
12.1.3. Asia Pacific Average Pricing Analysis
12.2. Asia Pacific Medical Tartaric Acid Market Size and Volume Forecast by Country
12.2.1. China
12.2.2. Japan
12.2.3. South Korea
12.2.4. India
12.2.5. Australia
12.2.6. Rest of Asia Pacific (APAC)
12.3. Absolute $ Opportunity Assessment by Country
12.4. Asia Pacific Medical Tartaric Acid Market Size and Volume Forecast by Application
12.4.1. Drug Industrial Raw Materials
12.4.2. Chiral Catalyst
12.4.3. Synthesis of Complex Natural Product Molecules
12.4.4. Antioxidant
12.4.5. Deoxidant
12.5. Basis Point Share (BPS) Analysis by Application
12.6. Y-o-Y Growth Projections by Application
12.7. Asia Pacific Medical Tartaric Acid Market Size and Volume Forecast by Type
12.7.1. Organic Synthesis
12.7.2. Artificially Synthesized
12.8. Basis Point Share (BPS) Analysis by Type
12.9. Y-o-Y Growth Projections by Type
12.10. Market Attractiveness/Growth Potential Analysis
12.10.1. By Country
12.10.2. By Product Type
12.10.3. By Application
12.10.4. By Sales Channel
12.11. Asia Pacific Medical Tartaric Acid Demand Share, 2019-2026
13. Middle East & Africa Medical Tartaric Acid Market Analysis and Forecast
13.1. Introduction
13.1.1. Basis Point Share (BPS) Analysis by Country
13.1.2. Y-o-Y Growth Projections by Country
13.1.3. Asia Pacific Average Pricing Analysis
13.2. Middle East & Africa Medical Tartaric Acid Market Size and Volume Forecast by Country
13.2.1. Saudi Arabia
13.2.2. South Africa
13.2.3. UAE
13.2.4. Rest of Middle East & Africa (MEA)
13.3. Absolute $ Opportunity Assessment by Country
13.4. Middle East & Africa Medical Tartaric Acid Market Size and Volume Forecast by Application
13.4.1. Drug Industrial Raw Materials
13.4.2. Chiral Catalyst
13.4.3. Synthesis of Complex Natural Product Molecules
13.4.4. Antioxidant
13.4.5. Deoxidant
13.5. Basis Point Share (BPS) Analysis by Application
13.6. Y-o-Y Growth Projections by Application
13.7. Middle East & Africa Medical Tartaric Acid Market Size and Volume Forecast by Type
13.7.1. Organic Synthesis
13.7.2. Artificially Synthesized
13.8. Basis Point Share (BPS) Analysis by Type
13.9. Y-o-Y Growth Projections by Type
13.10. Market Attractiveness/Growth Potential Analysis
13.10.1. By Country
13.10.2. By Product Type
13.10.3. By Application
13.10.4. By Sales Channel
13.11. Middle East & Africa Medical Tartaric Acid Demand Share, 2019-2026
14. Competition Landscape
14.1. Global Medical Tartaric Acid Market: Market Share Analysis
14.2. Medical Tartaric Acid Distributors and Customers
14.3. Medical Tartaric Acid Market: Competitive Dashboard
14.4. Company Profiles (Details Overview, Financials, Developments, Strategy)
14.4.1. Giovanni Randi S.P.A. Randi Group
14.4.1.1. Overview
14.4.1.2. Financials
14.4.1.3. Developments
14.4.1.4. Strategic Outlook
14.4.2. Boehringer-Ingelheim
14.4.2.1. Overview
14.4.2.2. Financials
14.4.2.3. Developments
14.4.2.4. Strategic Outlook
14.4.3. Hangzhou Bao Jing Biochemical Co., LTD
14.4.3.1. Overview
14.4.3.2. Financials
14.4.3.3. Developments
14.4.3.4. Strategic Outlook
14.4.4. Chang Mao Biochemistry Engineering Co., LTD
14.4.4.1. Overview
14.4.4.2. Financials
14.4.4.3. Developments
14.4.4.4. Strategic Outlook
14.4.5. SYNFINE
14.4.5.1. Overview
14.4.5.2. Financials
14.4.5.3. Developments
14.4.5.4. Strategic Outlook
14.4.6. CARBOMER
14.4.6.1. Overview
14.4.6.2. Financials
14.4.6.3. Developments
14.4.6.4. Strategic Outlook
14.4.7. Wonda Science
14.4.7.1. Overview
14.4.7.2. Financials
14.4.7.3. Developments
14.4.7.4. Strategic Outlook
14.4.8. CAMBREX
14.4.8.1. Overview
14.4.8.2. Financials
14.4.8.3. Developments
14.4.8.4. Strategic Outlook
14.4.9. Labseeker Inc
14.4.9.1. Overview
14.4.9.2. Financials
14.4.9.3. Developments
14.4.9.4. Strategic Outlook
14.4.10. GARAN S.K
14.4.10.1. Overview
14.4.10.2. Financials
14.4.10.3. Developments
14.4.10.4. Strategic Outlook
14.4.11. AlliChem, LLC
14.4.11.1. Overview
14.4.11.2. Financials
14.4.11.3. Developments
14.4.11.4. Strategic Outlook
14.4.12. COMPANY 12
14.4.12.1. Overview
14.4.12.2. Financials
14.4.12.3. Developments
14.4.12.4. Strategic Outlook
14.4.13. COMPANY 13
14.4.13.1. Overview
14.4.13.2. Financials
14.4.13.3. Developments
14.4.13.4. Strategic Outlook
14.4.14. COMPANY 14
14.4.14.1. Overview
14.4.14.2. Financials
14.4.14.3. Developments
14.4.14.4. Strategic Outlook
14.4.15. COMPANY 15
14.4.15.1. Overview
14.4.15.2. Financials
14.4.15.3. Developments
14.4.15.4. Strategic Outlook
14.4.16. COMPANY 16
14.4.16.1. Overview
14.4.16.2. Financials
14.4.16.3. Developments
14.4.16.4. Strategic Outlook
14.4.17. COMPANY 17
14.4.17.1. Overview
14.4.17.2. Financials
14.4.17.3. Developments
14.4.17.4. Strategic Outlook
14.4.18. COMPANY 18
14.4.18.1. Overview
14.4.18.2. Financials
14.4.18.3. Developments
14.4.18.4. Strategic Outlook
14.4.19. COMPANY 19
14.4.19.1. Overview
14.4.19.2. Financials
14.4.19.3. Developments
14.4.19.4. Strategic Outlook
14.4.20. COMPANY 20
14.4.20.1. Overview
14.4.20.2. Financials
14.4.20.3. Developments
14.4.20.4. Strategic Outlook